DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 1.18% to $129.31 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.05% to 7,411.98 and the Dow Jones Industrial Average rising 0.46% to 51,947.25.
The stock's fall snapped a two-day winning streak.
Gilead Sciences Inc. closed 17.79% short of its 52-week high of $157.29, which the company achieved on February 11th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.59% to $263.40, Pfizer Inc. $(PFE)$ fell 0.16% to $24.54, and Abbott Laboratories $(ABT)$ rose 2.29% to $103.06.
Trading volume (5.4 M) remained 2.4 million below its 50-day average volume of 7.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 24, 2026 16:36 ET (20:36 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.